– USA, NY – Trellus Health plc (LON: TRLS), commercializing a scientifically validated, personalized resilience-driven self-management solution for chronic health conditions, today announced the appointment of current Senior Independent Director – Dr. Dan Mahony – as Non-Executive Chairman with immediate effect, succeeding Julian Baines who stepped down from the Board.
About Dr. Daniel Mahony
Dan has over 25 years of experience within global healthcare covering biotechnology, medical technology, and healthcare services. Dan was appointed as Entrepreneur-in-Residence at Evotec (UK) Limited in October 2021 and is responsible for the EVOequity investment portfolio. Before joining Evotec, he was Co-Head of Healthcare at Polar Capital where he launched the healthcare business in 2007, growing it to over $4 billion of assets under management. Dan was formerly head of European healthcare research at Morgan Stanley, an analyst at ING Barings Furman Selz in New York, and a postdoctoral scientist at DNAX Research Institute in Palo Alto.
Dan chairs the Board of the BioIndustry Association, the industry trade association for UK life sciences, and holds non-executive directorships at the Wellcome Sanger Institute (a world-leading genomics research center), Sernova (a Canadian TSX-listed cell therapy company), Curexsys (a German privately-held biotechnology company) and Keepabl (a UK based, privately-owned provider of SaaS solutions for GDPR compliance). In 2022, he was appointed as the Life Sciences Investment Envoy by the UK Government.
About Trellus Health plc
Trellus Health is the first resilience-based digital health company focused on the intersection of chronic illness and mental health. Trellus Health integrates its proprietary resilience-based methodology with the technology, tools, and team to deliver a whole-person technology-enhanced experience that results in relieving disease burden, building self-management skills, and promoting individual health behaviors that enable thriving in the face of a chronic condition. Through its TrellusElevate connected health platform and companion App, the company addresses both physical and behavioral health together, in context, to improve outcomes and reduce healthcare costs across the healthcare ecosystem.
The Company was founded by Mount Sinai faculty members Marla C. Dubinsky, MD, and Laurie Keefer, Ph.D., both with decades of combined experience in IBD and psychogastroenterology, respectively. Trellus Health’s patent-pending GRITT resilience assessment and personalized resilience training methodology was developed and validated at the Mount Sinai Health System to build resilience and wellness for improved outcomes at a lower cost.
For more information: https://trellushealth.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
